Companies similar to COYA THERAPEUTICS
Sign up to Download

1-30 of 3,074,138 results

  • coyatherapeutics.com
  • 4
  • 1
  • 19
We are a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells. We are currently developing our multi-modality Treg therapies for neurodegenerative, autoimmune, and..

Relevance: 40.87575
  • www.biosion.com
  • 1
  • 1
We are a clinical-stage biotechnology company committed to developing breakthrough antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases...

Relevance: 39.412796
  • www.deverratx.com
  • 1
  • 1
  • 4
Deverra is a clinical-stage biotechnology company developing universal donor cell therapy treatments to fight cancer and other life-threatening diseases... Deverra Therapeutics, Inc. is a clinical stage biotechnology company located in Seattle,..

Relevance: 39.358723
  • pdcbio.com
  • 3
  • 1
  • 2
PDC Therapeutics is a biotechnology start-up committed to advancing smart nanomedicines for therapies with no compromise through a Polymer-Drug Conjugate technology approach that yields an optimal therapeutic index... PDC Therapeutics is a clinical-..

Relevance: 38.606094
  • celularity.com
  • 24
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent..

Relevance: 38.23429
  • imux.com
  • 5
  • 8
  • 22
Immunic is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases... Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective..

Relevance: 38.02201
  • ingeneron.com
  • 2
  • 2
  • 11
InGeneron is a clinical-stage biotechnology company developing cell-based therapies to redefine the standard of care in orthopedics... At InGeneron we use the term "regenerative cell therapy" since there are many different cell types and..

Relevance: 37.918472
  • medtechalert.com
  • 3
  • 19
Verge Genomics, a clinical-stage biotechnology company transforming drug discovery using artificial intelligence and human data,... DEM BioPharma, an immune-oncology company developing therapies that target signals on cancer cells and myeloid.....

Relevance: 35.641476
  • priovanttx.com
  • 1
  • 55
Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the greatest morbidity and mortality. We are developing oral brepocitinib, a potential first-in-class dual inhibitor of..

Relevance: 35.40584
  • novabiotics.co.uk
  • 1
  • 3
A leading clinical-stage biotechnology company focused on the design and development of first-in-class anti-infectives for difficult-to-treat diseases Novabiotics - a leading clinical-stage biotechnology company focused on the design and development..

Relevance: 35.126217
  • exumabio.com
  • 1
  • 4
  • 12
EXUMA is a clinical-stage biotechnology company developing gene vector delivery solutions and products to improve patient access to innovation in the cell and gene therapy space... EXUMA Biotech is a clinical-stage biotech company advancing gene..

Relevance: 34.905663
  • okogen.com
  • 2
  • 4
Okogen is an ophthalmic specialty pharmaceutical company focused on developing innovative therapies to treat adenoviral conjunctivitis... Our lead product candidate, OKG-0502, is being developed to treat adenoviral conjunctivitis (also known as pink..

Relevance: 34.470688
  • alphageneron.com
  • 1
  • 1
  • 7
Alphageneron Pharmaceuticals, Inc., is a privately-held clinical stage biotechnology company, developing targeted natural killer (NK) cell therapies which are supported by Companion Diagnostics. Alphageneron's team is comprised of industry veterans..

Relevance: 34.448013
  • www.evommune.com
  • 24
Evommune is a clinical stage biotechnology company discovering and developing novel therapies to treat immune-mediated chronic inflammatory diseases... Our programs are designed to advance therapies for chronic inflammatory diseases in underserved..

Relevance: 33.943626
  • pharmtechfocus.com
  • 3
  • 18
Quince Therapeutics, a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, announced... BioSenic, the clinical stage company specializing in serious autoimmune/inflammatory diseases and..

Relevance: 33.78108
  • www.athersys.com
  • 5
  • 2
  • 16
Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life. Our focus is on the treatment of medical conditions where there is significant..

Relevance: 33.771282
  • www.kuurtx.com
  • 2
  • 2
  • 19
Athenex is a clinical stage biotechnology company focused on the development of autologous and allogeneic NKT cell therapies to treat cancers. Our goal is to become a global leader in bringing innovative cancer treatments to the market and improving..

Relevance: 33.51233
  • www.aptose.com
  • 2
  • 1
  • 17
Aptose Biosciences is a clinical-stage biotechnology company developing differentiated therapies to address unmet medical needs in oncology, with a particular focus on hematologic malignancies. Aptose is advancing new therapeutics focused on well..

Relevance: 33.24283
  • www.stormtherapeutics.com
  • 2
  • 2
  • 14
STORM Therapeutics (STORM) is a clinical stage biotechnology company creating novel therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases. There are more than 150 RNA modifications reported and approximately 300..

Relevance: 33.17832
  • treeway.nl
  • 1
  • 2
  • 7
Treeway is a clinical-stage biotechnology company with a mission to develop therapies to cure ALS. Founded in 2012 by two ALS patients, Treeway is committed to developing drugs that first delay disease progression, then halt or control the disease..

Relevance: 33.166916
  • www.artivabio.com
  • 5
  • 1
  • 13
Artiva Biotherapeutics is a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies. Our lead product candidate, AlloNK®, is a non-genetically modified, cryopreserved NK cell therapy being evaluated in..

Relevance: 32.95988
  • www.equilliumbio.com
  • 8
  • 4
Bioniz is a clinical-stage biopharmaceutical company developing precision cytokine targeted therapies for the treatment of immuno-inflammatory diseases. Bioniz's platform incorporates world class expertise in cytokine biology to advance a novel..

Relevance: 32.63716
  • www.filtricine.com
  • 1
  • 20
Filtricine, Inc. is a clinical stage biotechnology company focused on developing novel products for cancer care. We are backed by venture capital and located in the San Francisco Bay Area of California. We are developing an innovative way to help..

Relevance: 32.572037
  • glycomimetics.com
  • 4
  • 2
  • 20
GlycoMimetics is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases. Our leading researchers leverage their deep understanding of the role that carbohydrates play..

Relevance: 32.45975
  • www.zenithepigenetics.com
  • 2
  • 2
  • 10
We are a clinical-stage biotechnology company developing best-in-class bromodomain and extra-terminal inhibitors (BETi) for the treatment of multiple cancers and other disorders with significant unmet medical need. Our goal is to be a leading..

Relevance: 32.389145
  • www.smart-immune.com
  • 7
  • 20
Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-empowered cell therapy platform to fully and rapidly re-arm the immune system, enabling next-generation allogeneic T-cell therapies for all. The company was founded..

Relevance: 32.166462
  • gridtherapeutics.com
  • 1
  • 1
  • 11
Grid Therapeutics is an emerging clinical stage biotechnology company located in Durham, North Carolina. We have made a commitment to our patients and families to develop better and safer therapies for cancer...

Relevance: 32.050503
  • affiris.com
  • 3
  • 2
  • 8
AFFiRiS is a clinical-stage biopharmaceutical company that pursues the ultimate aim to improve the lives of patients suffering from chronic diseases by providing specific active immunotherapies (SAIT) based on its proprietary patented AFFITOME®..

Relevance: 31.82262
  • mdxlifesciences.com
  • 2
  • 2
MDX LIFESCIENCES, Inc. is a clinical stage biotechnology company developing autologous transplantation for tissue and organ regeneration... Our development programs are primarily focused Myocardial Ischemia, reperfusion injury and neurodegenerative..

Relevance: 31.77205
  • elganpharma.com
  • 3
Elgan Pharma is a late-stage neonatology-focused biotechnology company, dedicated to developing therapies for preterm infants and other neonatal indications...

Relevance: 31.668737